CFS Assessment Symposium
Immunological Aspects of Chronic Fatigue Syndrome

Literature Review

1. Hanson SJ, Gause W, Natelson B: Detection of immunologically significant factors for chronic fatigue syndrome using neural-network classifiers. Clin Diagn Lab Immunol 2001; 8: 658-62.
   
2. Patarca-Montero R, Antoni M, Fletcher MA, Klimas NG: Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 2001; 8: 51-64.
   
3. Ablashi DV, Eastman HB, Owen CB, et al: Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000; 16: 179-91.
   
4. De Meirleir K, Bisbal C, Campine I, et al: A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000; 108: 99-105.
   
5. Evengard B, Schacterle RS, Komaroff AL: Chronic fatigue syndrome: new insights and old ignorance. J Intern Med 1999; 246: 455-69.
   
6. Whiteside TL, Friberg D: Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998; 105: 27S-34S.
   
7. Glaser R, Kiecolt-Glaser JK: Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 1998; 105: 35S-42S.
   
8. von Mikecz A, Konstantinov K, Buchwald DS, Gerace L, Tan EM: High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 1997; 40: 295-305.
   
9. Mawle AC, Nisenbaum R, Dobbins JG, et al: Immune responses associated with chronic fatigue syndrome: a case- control study. J Infect Dis 1997; 175: 136-41.
   
10. Moldofsky H: Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv Neuroimmunol 1995;5: 39-56.